Ireland
--:--IST
Starting soon Observational

Within-Session Repeatability of EUS-Guided Portal Pressure Gradient Measurement

NCT07877298 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2027-01-01
Last updated
2026-11-13

Condition(s) studied

Portal HypertensionChronic Liver DiseaseLiver Cirrhosis

Investigational drug(s) / intervention(s)

Repeated EUS-Guided Portal Pressure Gradient Measurement

Repeated EUS-Guided Portal Pressure Gradient Measurement: During a clinically indicated EUS-PPG procedure, each participant undergoes a second complete EUS-PPG measurement set in the same session. For each set, pressures in a hepatic vein and an intrahepatic portal vein branch are measured in triplicate using the same 22-gauge measurement chain. Before the repeat set, the system is flushed, the needle is withdrawn with one of the allowed techniques, the transducer is recalibrated, and the target vessels are independently re-identified and punctured. No treatment or portal-pressure-altering intervention occurs between the two sets.

Study summary

This prospective multicentre observational reliability study will determine how much a repeated endoscopic ultrasound-guided portal pressure gradient (EUS-PPG) measurement differs from the first measurement in the same patient during the same procedural session. Each participant will undergo two complete EUS-PPG measurement sets using an identical 22-gauge measurement setup. The study will quantify within-session repeatability when the same expert performs both sets and inter-operator reproducibility when different operators perform the sets.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age 18 years or older * Clinical indication for EUS-guided portal pressure gradient measurement established independently of the study * Written informed consent, including consent for the additional measurement set Exclusion Criteria: * Contraindication to endoscopy, sedation, or endosonography-guided vascular puncture * Non-correctable coagulation disorder * Hemodynamic instability at the time of the procedure * Any intervention between the two measurement sets that may alter portal pressure, including fluid administration beyond maintenance requirements, vasoactive substances, paracentesis, or variceal band ligation * Technically non-evaluable first measurement set * Pregnancy or breastfeeding * Inability to provide informed consent

Primary outcome measure(s)

  • Within-session repeatability coefficient of EUS-PPG measured by the same expert operator — During the index EUS-PPG procedure
    The repeatability coefficient will be calculated as 2.77 multiplied by the within-subject standard deviation of paired EUS-PPG measurements in the same-expert group. It will be reported in mmHg and as a percentage of the cohort mean, with a 95% confidence interval.

Trial sites (5)

FacilityCityRegionStatus
UZ Leuven Leuven Belgium
Centre hospitalier de l'Université de Montréal (CHUM) Montreal Quebec
McGill University Health Centre Montreal Quebec
University Hospital Muenster Münster North Rhine-Westphalia
Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome Lazio
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07877298 on ClinicalTrials.gov ↗ ← All trials in Germany